BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Biotech Beach

  ImmunoCellular Therapeutics, Ltd Granted Monoclonal Antibody Technology Patent

  April 29, 2009

   · 

  1 min read
• BioMidwest

  [1} Eliminates Preferred Rights Plan

  April 29, 2009

   · 

  1 min read
• Business

  Allos Therapeutics, Inc. to Report First Quarter 2009 Results on May 5, 2009

  April 29, 2009

   · 

  1 min read
• Deals

  ABC Laboratories, Inc. Announces Merger with Leading Residue Lab Morse Laboratories, Inc., Acquisition Creates Leader in Residue Chemistry

  April 29, 2009

   · 

  1 min read
• Business

  Dynavax Technologies Corporation Announces First Quarter 2009 Financial Results

  April 29, 2009

   · 

  1 min read
• Business

  Ceragenix Pharmaceuticals, Inc. and MAST Biosurgery, Inc. Enter into Joint Development Agreement for New Antimicrobial Surgical Products

  April 29, 2009

   · 

  5 min read
• LAB Research Inc. Secures $7.5 Million Financing from Investissement Qubec

  April 29, 2009

   · 

  2 min read
• Drug Development

  Antigenics Inc. (New York) Brain Cancer Vaccine Gets Orphan Drug Status

  April 29, 2009

   · 

  4 min read
• Policy

  FDA Extends Action Date for United Therapeutics Corporation’s Inhaled Treprostinil (Tyvaso) New Drug Application by Three Months

  April 29, 2009

   · 

  2 min read
• Drug Development

  Novartis AG MS Drug FTY720 Effective But Safety An Issue

  April 29, 2009

   · 

  1 min read